CD4 and COVID-19: Previous data on acute and chronic viral infection (34–36), including SARS-CoV-1 and MERS-CoV, as well as several studies analyzing SARS-CoV-2 T cell responses during or early after COVID-19, have shown that CD4+ T cells play a central role in cellular immunity to SARS-CoV-2.